Side effect field guide

GLP-1 side effects, week by week

Side effects on Ozempic, Wegovy, Mounjaro and Zepbound follow a schedule. Here is when each one usually shows up, what reduces it, and the short list that means stop reading and call someone.

44%Reported nausea in the Wegovy adult trials, vs 16% on placebo
Day 1–3The usual peak window after a weekly injection
Week 5–8Where most people abandon treatment: the first dose increase
27.3%Share of 25,000+ GLP-1 posts we analysed that were about side effects

Key takeaways

  • GLP-1 side effects follow a schedule. They concentrate in the 24–72 hours after an injection and spike again after every dose increase, rather than building steadily over months.
  • Nausea, diarrhoea and vomiting are the three most reported reactions in the trials, at 44%, 30% and 25% respectively — but under 2% of people stopped treatment because of any of them.
  • Constipation is the symptom people underestimate and the one most likely to still be there at month six.
  • A short list of symptoms are not side effects to manage but reasons to seek care the same day. They are at the bottom of this page.
  • Most of what makes side effects worse is modifiable: escalating too fast, eating the same portions, drinking too little, and not knowing which day of the week is going to be the bad one.

The side effect timeline, week by week

The first eight weeks are the hardest, and not because your body is "getting used to it" in some vague way — it is because that is when the dose is climbing. Every standard titration schedule steps up roughly every four weeks, and each step restarts the adjustment.

Typical pattern reported on standard four-week titration. Individual experience varies widely; this is a map, not a prediction.
PeriodWhat usually shows upWhat it usually means
Week 1–2
Starting dose
Mild nausea, early fullness, burping, food tasting less appealing. Appetite drops noticeably for some people and barely at all for others.Working as expected. The starting dose is deliberately sub-therapeutic; it exists to let your gut adapt, not to produce weight loss.
Week 3–4Constipation often arrives here. Nausea usually settles somewhat. Portion sizes start feeling wrong.Fibre and fluid intake usually have not caught up with the drop in food volume.
Week 5–8
First dose increase
Symptoms return, frequently worse than week 1. Fatigue, sulfur burps, reflux.The most common point of abandoning treatment. Also the most common point where slowing the escalation would have fixed it.
Month 3–5Gastrointestinal symptoms generally ease between increases. Hair shedding may begin. Muscle loss becomes the thing to actively manage.Hair shedding is telogen effluvium from rapid weight loss, not the drug attacking follicles. It is usually temporary.
Month 6+
Maintenance dose
For most people, mostly quiet. Constipation is the symptom most likely to persist. Fatigue that persists is worth investigating rather than accepting.Persistent fatigue at a stable dose often traces to inadequate protein or calories, not to the medication itself.

The weekly cycle after each shot

Once you are on a weekly injection, side effects have a rhythm, and knowing yours is worth more than any general advice on this page.

Commonly reported pattern for once-weekly semaglutide and tirzepatide.
Day after injectionTypical experience
Day 0–1Often quiet. Some people feel nothing for the first 12 hours.
Day 1–3Peak window. Nausea, fatigue and appetite suppression are usually strongest here.
Day 4–5Easing. Appetite often starts returning.
Day 6–7Trough. Some people notice hunger and food noise returning before the next dose — a signal worth reporting if it is consistent.

Two practical consequences. First, pick your injection day around your life: if Tuesday and Wednesday are your worst days, do not inject on Friday and write off every weekend. Second, if food noise reliably returns on day 6 or 7, that is useful clinical information about dose adequacy, and it is exactly the kind of pattern nobody remembers accurately at an appointment three weeks later.

What we see in the data

Across 25,000+ GLP-1 discussions we analysed, side effects accounted for 27.3% of the conversation — and the recurring theme was not severity. It was unpredictability. People cope well with a bad Tuesday they saw coming and badly with the same Tuesday when it feels random.

Every common side effect, and what to do

Nausea

Reported by 44% in the Wegovy trials versus 16% on placebo. Usually worst in the 48 hours after an injection and after each dose increase. Smaller portions, eating slowly, stopping at the first sign of fullness, and avoiding high-fat meals on peak days all help. Persistent vomiting is a different problem — see below.

Constipation

The one people plan for least. Eating far less food means far less fibre and fluid, and slowed gut transit compounds it. Deliberate fibre, deliberate water and daily movement work better than waiting for it to resolve. Raise it with your prescriber before it becomes weeks old.

Diarrhoea

30% versus 16% on placebo. Often alternates with constipation. The risk is dehydration, particularly combined with reduced fluid intake from eating less.

Vomiting

25% versus 6% on placebo. Occasional vomiting after overeating is common and usually self-limiting. Repeated vomiting that stops you keeping fluids down is the route to acute kidney injury and needs a call, not patience.

Fatigue

Very frequently an intake problem rather than a drug effect. When appetite drops sharply, calories and protein often fall further than intended, and the tiredness follows. Check protein first — the protein target calculator gives you a number to aim at.

Sulfur burps

Egg-smelling burps, sometimes with nausea. Linked to delayed gastric emptying and slower protein digestion. Smaller meals and less fat on peak days tend to reduce them.

Reflux and heartburn

Food sitting in the stomach longer means more opportunity to come back up. Not lying down within a few hours of eating helps more than most interventions.

Hair shedding

Usually starts around month three to four. It is telogen effluvium, the standard response to rapid weight loss and reduced protein intake, and it is normally temporary. Adequate protein is the main lever — the hair shedding guide has the month-by-month timeline and the patterns that mean something else.

Injection site reactions

Redness, itching or a small lump. Rotating sites reduces recurrence. Spreading redness with warmth and pain is a possible infection and needs looking at.

Hypoglycaemia

Uncommon on a GLP-1 alone. Meaningfully more likely if you also take insulin or a sulfonylurea, and that combination usually requires dose adjustment by your prescriber.

Why dose increases are the hard part

Most people who abandon a GLP-1 do so during escalation, not at the top dose. The standard schedule steps up every four weeks, and that cadence is a default, not a law of nature.

If a step lands badly, the options are staying at the current dose longer, or stepping back down and re-climbing more slowly. Both are normal clinical decisions. Neither is failure, and both are your prescriber's call, not something to improvise by splitting doses yourself.

What is worth doing before that appointment: knowing exactly which days were bad, at which dose, and what you had eaten. "It was rough" gets you sympathy. "Days two and three after each increase, both times, and I could not keep water down on the second one" gets you a plan. Our titration schedule tool maps the standard steps and dates so you can see where you are in the sequence.

If you miss a dose during this window, the answer depends on the drug and how long it has been. The missed dose calculator gives you what the label actually says rather than what a forum says.

What actually reduces side effects

  1. Eat less at a sitting, not less often. The stomach is emptying slower; volume is the trigger far more than food type.
  2. Stop at the first sign of full. On a GLP-1 the gap between comfortable and unwell is much narrower and arrives sooner than you are used to.
  3. Front-load protein. Appetite is most reliable early in the day and after the peak window has passed.
  4. Drink more than feels necessary. Reduced food means reduced fluid intake, and dehydration underlies a large share of GLP-1 emergency presentations.
  5. Keep fat low on peak days. Fatty meals sit longest and are the most common trigger for a bad night.
  6. Time the injection deliberately. Pick the day that puts the peak window where your week can absorb it.
  7. Slow the escalation if a step lands badly. With your prescriber. An extra four weeks at a tolerable dose beats quitting at week nine.

When it is not a side effect

These are not symptoms to manage. They are reasons to seek care.

Same-day medical attention:

  • Severe, persistent abdominal pain, especially radiating to the back, with or without vomiting — possible pancreatitis.
  • Vomiting you cannot stop for more than 24 hours, or any inability to keep fluids down — dehydration and acute kidney injury risk.
  • Sudden vision loss or rapidly worsening eyesight — the EMA confirmed NAION as a very rare side effect of semaglutide in 2025.
  • Persistent vomiting with no bowel movement and a distended abdomen — possible obstruction.
  • Swelling of the face, lips or throat, or difficulty breathing — allergic reaction.
  • A lump in the neck, hoarseness, difficulty swallowing or persistent shortness of breath — the label asks you to report these.
  • Low blood sugar symptoms if you also take insulin or a sulfonylurea — shaking, sweating, confusion.

Before any surgery, endoscopy or sedation, including dental work, tell the team you take a GLP-1. Delayed gastric emptying means a standard fast may not have emptied your stomach, and that is an aspiration risk they can only plan around if they know. The pre-procedure guide covers what the October 2024 multi-society guidance actually says.

For the wider evidence picture on each of these, see are GLP-1 medications safe?

Common questions

How long do GLP-1 side effects last?
For most people the gastrointestinal symptoms ease within two to four weeks at a stable dose, then return briefly after each dose increase. Constipation is the most likely to persist beyond month six. Symptoms that are still severe after several weeks at an unchanged dose are worth reviewing with your prescriber rather than waiting out.
Which day after the injection is worst?
Most people report days one to three after the shot as the peak window, with day zero often quiet and days six to seven the trough. The pattern is individual and consistent enough to plan around once you have tracked it for a few weeks.
Do side effects mean the medication is working?
No. Side effect severity does not track with weight loss. Plenty of people have strong results with mild symptoms, and vice versa. Tolerating misery is not evidence of progress.
Can I take anti-nausea medication with a GLP-1?
That is a prescriber decision. Some anti-emetics interact with other medications or mask symptoms that need evaluating. Ask rather than self-medicate, particularly if the nausea is new at a stable dose.
Why am I so tired on a GLP-1?
The most common explanation is that calorie and protein intake fell further than intended when appetite dropped. Check protein against a target first. Fatigue that persists at a stable dose with adequate intake deserves investigation, including for dehydration and anaemia.

Sources

Every figure on this page traces to one of these. Regulatory documents and peer-reviewed primary research only — see our editorial policy for what we accept as a source.

  1. WEGOVY (semaglutide) injection, US prescribing information. FDA, 2025. View source
  2. Sodhi M et al. Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss. JAMA, 2023. View source
  3. PRAC concludes eye condition NAION is a very rare side effect of semaglutide medicines Ozempic, Rybelsus and Wegovy. European Medicines Agency, 2025. View source
  4. The science of safety: adverse effects of GLP-1 receptor agonists as glucose-lowering and obesity medications. Journal of Clinical Investigation. View source
  5. GLP-1 Agonists: What They Are, How They Work & Side Effects. Cleveland Clinic. View source
  6. Wilding JPH et al. Impact of Semaglutide on Body Composition in Adults With Overweight or Obesity: Exploratory Analysis of the STEP 1 Study. Journal of the Endocrine Society, 2021. View source

Find your own pattern

General timelines only get you so far. GLPme logs symptoms against dose day so you can see which days are actually yours, and hand a clinician the pattern instead of a guess.

Download on the App Store

Keep reading